904. Highly Treatment-Experienced Patients: Novel Drugs, Future Study Designs
Session: Symposium: HIV State of the Art
Friday, October 5, 2018: 9:10 AM
Room: N Hall D
Judith Currier, MD, MSc, MPH, FIDSA, University of California, Los Angeles, Los Angeles, CA

Dr Currier is a Professor of Medicine and Chief of the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA and currently serves as the principal investigator for ACTG Network.Dr Currier is involved in clinical research in the area of HIV therapeutics with a special interest in sex differences in antiretroviral therapy.


J. Currier, Theratechnologies: Grant Investigator , Grant recipient .

See more of: HIV State of the Art
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.